Type 2 Diabetes and Inflammation; Correlation of commonly used inflammatory biomarker with marker of glycemic control

Anupama Patne, P J Hisalkar, Akanksha Dubey


Background: India leads the world with the largest number of Diabetic subjects, hence can be called as Diabetic Capital of World. Diabetes is a serious, chronic disease that occurs due to defects in insulin secretion or insulin action or may be both. Optimal glycemic control is fundamental and still is the main
therapeutic objective for the managing and prevention micro and macrovascular complications arising from diabetes that can impact on quality of life. The linkage of inflammation and type 2 diabetes mellitus (T2DM) has been extensively investigated for over a decade. The main objective of the study is to identify correlation between glycemic control and inflammation.
Materials and Methods: Total 500 subjects were studied which were divided into two groups of 250 of Diabetic cases and Healthy controls after defining proper inclusion and exclusion criteria. Gender wise distribution was also done. HbA1C and CRP were estimated on fully automated analyzers.
Results: The result had shown that cases have significantly elevated HbA1C and CRP when compared to age and sex matched healthy controls with p<0.0001. We also identified Pearson correlation between CRP and HbA1C found to be correlated, however positive correlation was weak.
Conclusion: We can conclude that in developing countries like India estimation of Glycated Hemoglobin and CRP can predict secondary complications of disease.

Keywords: Type 2 Diabetes Mellitus, HbA1C, Glycemic Control, CRP, Inflammation.

Full Text: